Overview
Elastoma (also known as juvenile elastoma or elastoma of childhood) is a rare benign connective tissue nevus characterized by an abnormal accumulation of elastic fibers in the dermis (the deeper layer of the skin). This condition primarily affects the skin, presenting as firm, flesh-colored to yellowish papules or nodules that may be isolated or grouped, often appearing on the trunk, limbs, or other body areas. The lesions are typically asymptomatic, meaning they do not cause pain or itching, though they may be of cosmetic concern. Histologically, elastomas show increased and sometimes disorganized elastic tissue within the dermis, distinguishing them from other connective tissue nevi that may involve collagen abnormalities. Elastomas can occur as isolated (sporadic) findings or may be associated with other conditions. Notably, multiple elastomas can be seen in the context of Buschke-Ollendorff syndrome (dermatofibrosis lenticularis disseminata with osteopoikilosis), which is an autosomal dominant condition caused by mutations in the LEMD3 gene. When elastomas occur in isolation without associated skeletal findings, they are generally considered benign and self-limited. The condition is classified under ICD-10 code Q82.8 (other specified congenital malformations of skin). There is no specific curative treatment for elastomas. Management is generally conservative, as the lesions are benign and do not undergo malignant transformation. If lesions are cosmetically bothersome, surgical excision may be considered, though recurrence is possible. Regular dermatologic follow-up may be recommended, particularly to evaluate for any associated systemic features. Genetic counseling may be appropriate when elastomas are part of a broader syndrome.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsDARTNet Institute — PHASE4
SkylineDx — NA
Bristol-Myers Squibb — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Elastoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Elastoma at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersUniversity of Michigan
📍 Ann Arbor, Michigan
👤 Janssen Research & Development, LLC Clinicaltrial
Mayo Clinic
📍 Jacksonville, Florida
University of Washington
📍 Seattle, Washington
👤 Janssen Research & Development, LLC Clinical Trial
University of Kentucky
📍 Lexington, Kentucky
Emory University School of Medicine
📍 Atlanta, Georgia
Huntsman Cancer Institute
📍 Salt Lake City, Utah
👤 Janssen Research & Development, LLC Clinical Trial
University of Kansas
📍 Kansas City, Kansas
Harvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
Travel Grants
No travel grants are currently matched to Elastoma.
Community
No community posts yet. Be the first to share your experience with Elastoma.
Start the conversation →Latest news about Elastoma
Disease timeline:
New recruiting trial: ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
A new clinical trial is recruiting patients for Elastoma
New recruiting trial: CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum
A new clinical trial is recruiting patients for Elastoma
New recruiting trial: PPI Supplementation to Fight ECtopIc Calcification in PXE
A new clinical trial is recruiting patients for Elastoma
New recruiting trial: Progression Assessment of PXE-associated Alterations
A new clinical trial is recruiting patients for Elastoma
New recruiting trial: The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
A new clinical trial is recruiting patients for Elastoma
New recruiting trial: The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
A new clinical trial is recruiting patients for Elastoma
New trial: MElanoma Research Lymph Node Prediction Implementation National_001
Phase NA trial recruiting.
New trial: Individualizing Treatment for Asthma in Primary Care (Full Study)
Phase PHASE4 trial recruiting. Inhaled corticosteroid (ICS)
New trial: A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
Phase PHASE2 trial recruiting. Relatlimab
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Elastoma
What is Elastoma?
Elastoma (also known as juvenile elastoma or elastoma of childhood) is a rare benign connective tissue nevus characterized by an abnormal accumulation of elastic fibers in the dermis (the deeper layer of the skin). This condition primarily affects the skin, presenting as firm, flesh-colored to yellowish papules or nodules that may be isolated or grouped, often appearing on the trunk, limbs, or other body areas. The lesions are typically asymptomatic, meaning they do not cause pain or itching, though they may be of cosmetic concern. Histologically, elastomas show increased and sometimes disorga
Which specialists treat Elastoma?
5 specialists and care centers treating Elastoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.